Correlation Between Cidara Therapeutics and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cidara Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cidara Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cidara Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Cidara Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cidara Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cidara Therapeutics and Corvus Pharmaceuticals.

Diversification Opportunities for Cidara Therapeutics and Corvus Pharmaceuticals

0.61

Correlation Coefficient

Cidara Therapeutics  Corvus Pharmaceuticals

Poor diversification

The 3 months correlation between Cidara and Corvus is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Cidara Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Cidara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cidara Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Cidara Therapeutics i.e., Cidara Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cidara Therapeutics and Corvus Pharmaceuticals

Given the investment horizon of 90 days Cidara Therapeutics is expected to generate 1.45 times less return on investment than Corvus Pharmaceuticals. But when comparing it to its historical volatility, Cidara Therapeutics is 1.14 times less risky than Corvus Pharmaceuticals. It trades about 0.23 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  404.00  in Corvus Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  505.00  from holding Corvus Pharmaceuticals or generate 125.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cidara Therapeutics  vs.  Corvus Pharmaceuticals

Cidara Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cidara Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Cidara Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Corvus Pharmaceuticals

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cidara Therapeutics and Corvus Pharmaceuticals

The main advantage of trading using opposite Cidara Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cidara Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Cidara Therapeutics and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.